Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Diffuse intrinsic pontine gliomas (DIPG) are highly aggressive and difficult to treat brain tumors found at the base of the brain. They are glial tumors, meaning they arise in the brain's glial tissues — tissues made up of cells that help support and protect the brain's neurons. These tumors are found in an area of the brainstem (the lowest, stem-like part of the brain) called the pons, which controls many of the body's most vital functions such as breathing, blood pressure, and heart rate.
Approximately 300 children are diagnosed with diffuse intrinsic pontine glioma (DIPG) each year, usually between the ages of 5 and 9. Although the prognosis for DIPG remains very poor, new research led by Dana-Farber/Boston Children's may provide the key to improved treatment options.
Children and adolescents with diffuse intrinsic pontine gliomas (DIPG) are treated at Dana-Farber/Boston Children's through our Glioma Program, one of the world's largest pediatric glioma treatment programs. Our brain tumor specialists have extensive expertise in treating all types of gliomas, including DIPGs.
Find more in-depth information on diffuse intrinsic pontine gliomas on the Dana-Farber/Boston Children's website, including answers to:
Appointments and Second Opinions